Compare MITK & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MITK | DRTS |
|---|---|---|
| Founded | 1983 | 2015 |
| Country | United States | Israel |
| Employees | N/A | 125 |
| Industry | Computer peripheral equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 536.1M | 546.5M |
| IPO Year | 1995 | N/A |
| Metric | MITK | DRTS |
|---|---|---|
| Price | $13.86 | $7.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $15.00 | $8.67 |
| AVG Volume (30 Days) | ★ 850.4K | 275.5K |
| Earning Date | 05-07-2026 | 03-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 171.43 | N/A |
| EPS | ★ 0.06 | N/A |
| Revenue | ★ $45,390,000.00 | N/A |
| Revenue This Year | $9.55 | N/A |
| Revenue Next Year | $8.07 | $965.57 |
| P/E Ratio | $238.33 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.93 | $2.30 |
| 52 Week High | $15.61 | $8.60 |
| Indicator | MITK | DRTS |
|---|---|---|
| Relative Strength Index (RSI) | 52.22 | 47.64 |
| Support Level | $13.68 | $6.90 |
| Resistance Level | $15.61 | $7.77 |
| Average True Range (ATR) | 0.64 | 0.45 |
| MACD | -0.21 | -0.01 |
| Stochastic Oscillator | 9.33 | 51.07 |
Mitek Systems Inc is engaged in the development, sale, and service of proprietary software solutions related to mobile imaging. The firm is a software development company with expertise in artificial intelligence, and machine learning. It serves more than 7,900 financial services organizations, financial technology (fintech) brands, telecommunications companies, and marketplace brands across the globe. The company's Mobile Deposit solution is used by consumers for mobile check deposits. The company's Mobile Verify verifies a user's identity online, enabling organizations to build safer digital communities, whereas CheckReader enables financial institutions to automatically extract data from a check image received across any deposit channel - branch, ATM, RDC, and mobile.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company derives maximum revenue from Israel.